Navigation Links
Commercial future for Model Gut
Date:2/26/2013

The Dynamic Gastric Model, developed from years of research at the Institute of Food Research, has taken significant steps towards improving its commercial use by food and drug companies worldwide.

IFR and the technology management company Plant Bioscience Limited (PBL) have secured funding from the Biotechnology and Biological Sciences Research Council (BBSRC) to further develop the Dynamic Gastric Model to validate and improve how well it simulates the release of nutrients or drugs in humans.

PBL has also signed an exclusive license agreement with Bioneer regarding use of the Dynamic Gastric Model (DGM). Bioneer has also acquired PBL's highly successful DGM contract research business (www.modelgut.com) which provides specialist DGM services to the pharmaceutical and food-related industries.

The DGM is based on 15 years of research at the Institute of Food Research, in partnership with PBL. It accurately simulates the physical and biochemical processes that occur within the human stomach. It is the world's first computer controlled, mechanical simulator of gastric digestion that works in real-time to process real chewed foods or meals and oral pharmaceutical or nutraceutical products.

The commercialisation of the model represents a significant achievement for IFR in developing research and making it commercially viable. It is an example of IFR's commitment to the translation of our science for the benefit of society and commerce.

IFR will continue to work with the DGM, as part of its core research into understanding the complex interaction between health, the food we eat and our gut. The new two-year project, with funding from the BBSRC's Super Follow on Fund scheme, is worth over 900k and will refine and improve models to ensure that IFR can continue its strategic research to determine how the nutritional quality and health benefits of the food we eat can be influenced by t
'/>"/>

Contact: Andrew Chapple
andrew.chapple@ifr.ac.uk
44-016-032-51490
Norwich BioScience Institutes
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Kessler Foundation implements Ekso Bionics first commercial robotic exoskeleton
2. A study confirms that long commercials evoke stronger emotions
3. Researchers take hibiscus efforts to commercialization
4. Sandia seeks commercial partners for revolutionary SpinDx medical diagnostic tool
5. NIST focuses on testing standards to support lab on a chip commercialization
6. Bed bugs are not repelled by commercial ultrasonic frequency devices
7. UC Berkeley, UCSF and Stanford join forces to help commercialize university innovations
8. The future of plant science - a technology perspective
9. The future of plant science a technology perspective
10. Is seaweed the future of biofuel?
11. Algae biofuels: the wave of the future
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Commercial future for Model Gut
(Date:5/19/2015)... Research and Markets ( ... the  "Genetic Testing Market Outlook 2018"  report ... ,A recent report, Genetic Testing Market Outlook ... current and future genetic testing market. A ... principles and types are covered in this ...
(Date:5/14/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/5whpxg/fingerprint ) has ... in Smart Mobile Devices " report to their ... a watershed year for fingerprint sensors in smartphones and ... gave fingerprint sensors a raison d,etre in the mobile ... a must-have feature in flagship smartphones. The ...
(Date:5/11/2015)... May 11, 2015  Synaptics Incorporated (NASDAQ: ... solutions, today announced the appointment of Wajid ... Financial Officer, reporting to Rick Bergman , ... Chief Financial Officer, Kathleen Bayless , who ... Mr. Ali brings extensive financial management expertise ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2
... noses and Microsoft Windows, infamous blue screen of death ... being made by a new research report appearing online ... Specifically, scientists now know exactly why we sneeze, what ... not work properly. Much like a temperamental computer, our ...
... Olympic athletes may be the best trained and physically ... susceptible to back pain. BackPainRelief.net is releasing an infographic ... injuries can be avoided. (Photo: ... for a number of injuries, and back pain is ...
... (July 30, 2012) When the longest cells in the body ... is no easy task. This is in part because these ... one meter in adult humans which is a lot ... order to reach the "command center" of the cell,s nucleus. ...
Cached Biology News:Allergies? Your sneeze is a biological response to the nose's 'blue screen of death' 2Backpainrelief.net Tackles Sports Injuries with Infographic 2Long-distance distress signal from periphery of injured nerve cells begins with locally made protein 2Long-distance distress signal from periphery of injured nerve cells begins with locally made protein 3
(Date:5/22/2015)... MA (PRWEB) May 22, 2015 ... the U.S. Department of Agriculture (USDA), Grain Inspection, ... five year contract to Charm Sciences to monitor ... Quantitative Test (water-based) and ROSA FAST Aflatoxin Quantitative ... Aflatoxin Quantitative Test uses Water Extraction Technology ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Knowledgent ... white paper that explores the potential of big data ... white paper was developed to help life sciences and ... leverage data to gain critical business insights. , The ... amounts of data driven by patient profiling, compliance and ...
(Date:5/22/2015)... Baylor Research Institute (BRI) at Dallas ... in Phoenix, AZ , today announce ... treatments for patients with a broad range of cancers. Aligning ... clinical trials and access to technology to drive the development ... bedside across Baylor Scott & White Health,s 49 ...
(Date:5/21/2015)... , May 21, 2015 /PRNewswire/ - SQI Diagnostics Inc. ... sciences company that develops and commercializes proprietary technologies and ... and operational results for the second fiscal quarter ended ... the Company continued to advance business with our existing ... Morris , President and CEO of SQI. "The delivery ...
Breaking Biology Technology:USDA-GIPSA (FGIS) Awards 5 Year Contract for Aflatoxin Tests to Charm Sciences 2New White Paper Explores the Potential of Big Data Analytics in Life Sciences and Healthcare 2Precision Medicine Collaboration to Increase Options for Cancer Patients 2Precision Medicine Collaboration to Increase Options for Cancer Patients 3Precision Medicine Collaboration to Increase Options for Cancer Patients 4SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8
... ProMetic Life Sciences Inc.,(TSX: PLI) ("ProMetic") today ... clinical trial in patients with chemotherapy-induced,anemia ("CIA") ... Hematology Association,held in Copenhagen, Denmark this week., ... Biology, presented data on,PBI-1402 in a poster ...
... /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. (NASDAQ: ANPI , ... company, today announced the market launch of Quill(TM) ... distribution,and sale in the U.S. and Europe., ... rapidly resorbing,polymer, is intended primarily for superficial wound ...
... Inc. (NYSE: BEC ), a leading developer, ... innovate complex biomedical tests,announces upcoming company presentations and ... (Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ), -- ... 25, 2008., -- July 28 - 31, ...
Cached Biology Technology:Positive clinical data for PBI-1402 presented at the Annual Congress of the European Hematology Association 2Positive clinical data for PBI-1402 presented at the Annual Congress of the European Hematology Association 3Angiotech announces market launch of Quill(TM) SRS MONODERM(TM) 2Angiotech announces market launch of Quill(TM) SRS MONODERM(TM) 3Angiotech announces market launch of Quill(TM) SRS MONODERM(TM) 4Upcoming Beckman Coulter Investor Events Second Half of 2008 2
NuCycl DAPI Kit Application: Flow Cytometry Reactivity: Human...
Request Info...
ChIP-GLAS kit for H10K-B microarray chips. Contains ChIP kit, GLAS kit, and hybridization kit. Additional reagents are required. Please see manual for details. Contains sufficient reagent for 20 reac...
...
Biology Products: